01591nam 2200385 450 991058334150332120230120003550.00-12-809445-10-12-809400-1(CKB)4330000000079374(MiAaPQ)EBC4856918(EXLCZ)99433000000007937420170530h20172017 uy 0engurcnu||||||||rdacontentrdamediardacarrierAdverse events and oncotargeted kinase inhibitors /Giuseppe TridenteLondon, England :Academic Press,2017.©20171 online resource (717 pages) illustrations, tablesIncludes bibliographical references at the end of each chapters and index.Introduction -- Kinases -- Kinase inhibitors -- Adverse events -- Imantinib -- Gefitinib -- Erlotinib -- Sorafenib -- Sunitinib -- Dasatinib -- Lapatinib -- Nilotinib -- Pazopanib -- Vandetanib -- Vemurafenib -- Crizotinib -- Ruxolitinib -- Axitinib -- Bosutinib -- Regorafenib -- Cabozantinib -- Ponatinib -- Dabrafenib -- Trametinib -- Afatinib -- Idelaisib -- Ibrutinib -- Overview -- Conclusion and perspectives.Protein-tyrosine kinaseInhibitorsProtein-tyrosine kinaseInhibitors.612.01516Tridente G.101335MiAaPQMiAaPQMiAaPQBOOK9910583341503321Adverse events and oncotargeted kinase inhibitors1916110UNINA01559nam0 22004213i 450 VAN0029128920250625123650.975N978146124338020250410d1993 |0itac50 baengUS|||| |||||i e bcrElectronics via Waveform AnalysisEdwin C. CraigNew York [etc.]Springer1993xii, 420 p.ill.24 cm00A79 (77-XX)Physics [MSC 2020]VANC023182MF94CxxCircuits, networks [MSC 2020]VANC027151MFCalculusKW:KDifferential equationsKW:KElectronicsKW:KElektronicsKW:KFourier seriesKW:KIntegrated circuitsKW:KMaximumKW:KUSNew YorkVANL000011CraigEdwin C.VANV170163771006Springer <editore>VANV108073650ITSOL20250627RICAhttps://doi.org/10.1007/978-1-4612-4338-0E-book – Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o ShibbolethBIBLIOTECA DEL DIPARTIMENTO DI MATEMATICA E FISICAIT-CE0120VAN08NVAN00291289BIBLIOTECA DEL DIPARTIMENTO DI MATEMATICA E FISICA08DLOAD e-Book 11429 08eMF11429 20250611 Electronics via Waveform Analysis4350607UNICAMPANIA